neobookRx
DrugsLevel 4 LocalisationS0SUSEML

Aluminium Hydroxide

Aluminium compoundAntacid

Indications

Registered South African indications:

  • Heartburn
  • Hyperacidity
  • Dyspepsia
  • Gastritis
  • Oesophageal reflux
  • Reflux oesophagitis
  • Peptic ulceration

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • In patients with symptoms of appendicitis since these medicines may increase the danger of perforation or rupture due to their constipating effects
  • In patients with hypophosphataemia due to the phosphate binding properties of aluminium salts
  • Presently taking a prescription antibiotic medicine containing any form of tetracycline

Cautions

  • Renal impairment
  • Elderly
  • Prolonged use
  • Cardiac failure
  • Oedema
  • Cirrhosis
  • Low sodium diets
  • Recently suffered gastrointestinal haemorrhage
  • Uremic patients not receiving dialysis
  • Bone resorption disorders (hypercalciuria, osteomalacia)
  • Fructose intolerance
  • Patients at risk of phosphate depletion

Adult dosage

Forms avail. in SA and covered in this monograph: sus

Indigestion
Heartburn
Hyperacidity
Dyspepsia
Gastritis
Oesophageal reflux with heartburn
Reflux oesophagitis
Peptic ulceration

  • Oral (sus): 600mg (5-10ml), 5-6 times daily, between meals and at bedtime

Paediatric dosage

Not established for use in children

Special populations

Pregnancy

  • Safe
  • Aluminium hydroxide may be used during pregnancy at normal recommended doses

Breastfeeding

  • Compatible
  • Aluminium is present in breast milk. Aluminium hydroxide may be used by breastfeeding mothers at normal recommended doses. The breastfed infant should be observed for occurrence of any adverse effects

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Central Nervous System Disorders

  • Encephalopathy
  • Dementia

Gastrointestinal Disorders

  • Nausea and vomiting
  • Constipation
  • Obstruction
  • Decreased bowel motility

Genitourinary Disorders

  • Dehydration
  • Chronic renal failure

Endocrine and Metabolic Disorders

  • Phosphate depletion

Musculoskeletal Disorders

  • Osteomalacia

Interactions

  • Allopurinol
  • Ascorbic acid
  • Atazanavir
  • Bisacodyl
  • Bismuth subcitrate
  • Bisphosphonate derivatives
  • Bosutinib
  • Calcium polystyrene sulfonate
  • Cefditoren
  • Cefuroxime
  • Chenodiol
  • Chloroquine
  • Cholic acid
  • Corticosteroids 
  • Dabigatran etexilate
  • Dasatinib
  • Deferasirox
  • Deferiprone
  • Delavirdine
  • Dolutegravir
  • Eltrombopag
  • Elvitegravir
  • Erlotinib
  • Ethambutol
  • Fexofenadine
  • Fosinopril
  • Gabapentin
  • Gefitinib
  • Hyoscyamine
  • Iron salts
  • Isoniazid
  • Itraconazole
  • Ketoconazole 
  • Lanthanum
  • Ledipasvir
  • Levothyroxine
  • Mequitazine
  • Mesalamine
  • Methenamine
  • Multivitamins
  • Fluoride
  • Minerals 
  • Mycophenolate
  • Neratinib
  • Nilotinib
  • Pazopanib
  • Penicillamine
  • Phosphate supplements
  • Potassium phosphate
  • Quinine
  • Quinolone antibiotics
  • Raltegravir
  • Rilpivirine
  • Riociguat
  • Sodium polystyrene sulfonate
  • Sotalol
  • Strontium ranelate
  • Sulpiride
  • Tetracycline derivatives
  • Trientine
  • Ursodiol
  • Velpatasvir
  • Vitamin D analogs

Monitoring

None routine. Specific cases may require

  • Calcium levels
  • Phosphorous levels

Mechanism of action

Aluminium hydroxide reacts chemically to neutralize or buffer existing quantities of stomach acids but has no direct effects on its production. The action increases gastric pH, providing symptomatic relief of hyperacidity.

Dosage forms

  • Suspension

Formulation

Suspension (per 5ml) 300mg

  • Amphojel (Akromed)

References

1. SAMF_12th Edition_Page 37 2. PI: Amphogel suspension, Akromed: Date of Registration; Jan 2005 https://drive.google.com/drive/folders/0B0xnChtF7vduVXZyR1puM21iQWs 3. U2D: Aluminium hydroxide: Drug information; Uptodate: Downloaded online 22 October 2018 https://www.uptodate.com/contents/aluminum-hydroxide-drug-information?source=search_result&search=aluminum%20hydroxide&selectedTitle=1~61 4. NAPOS The Drug Database for Acute Porphyria: Aluminium hydroxide; Accessed online 22 October 2018 http://www.drugs-porphyria.org/languages/UnitedKingdom/s1.php?l=gbr 5. South African Institute for Drug-Free Sport; Aluminium hydroxide; Accessed online 22 October 2018 http://www.drugfreesport.org.za/online-medication-check/ 6. SmPC: Maalox 175mg/200mg Oral Suspension (SANOFI); Last updated on 22 Oct 2019; Downloaded: 04 mar 2020 - [https://www.medicines.org.uk/emc/product/2716/smpc] 7. Clinical Pharmacologist - Dr. M Irhuma [https://trello.com/c/rMS5bjHg/321-list-of-hot-monographs] 8. http://porphyriadrugs.com/ (NAPOS) (accessed on 21/1/2020 *No SPC available

Brands & products

12 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

suspensionGeneric· 9 products

from R0.25/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Dicyclomine co gel400 mg/10ml200S2R50.26R0.25R29.27702725002
Alumag D400 mg/10ml350S2R87.37R0.25R42.11703640002
Betaclomin Gel 200 mg/10ml350S2R94.06R0.27R44.43707899028
Alumag d400 mg/10ml200S2R57.75R0.29R31.86703640001
Betaclomin Gel 200 mg/10ml200S2R61.49R0.31R33.16707899001
Dicyclomine co gel400 mg/10ml100S2R34.19R0.34R23.71702725001
Gelumen400 mg/10ml200S2R68.13R0.34R35.46789933101
Betaclomin Gel 400 mg/10ml100S2R39.84R0.40R25.67707899044
Microgel50 mg350S2R170.67R0.49R70.93743054008

syrupGeneric· 1 product

from R0.28/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Meddev5 mg200S2R56.35R0.28R31.383006688001

powderGeneric· 2 products

from R0.44/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Bisma-Rex Powder19 mg450S2R197.36R0.44R80.17709776002
Bisma-Rex Powder19 mg150S2R77.88R0.52R38.83709776001
Trade names (1)
  • Amphojel

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Interacts with 28 known drugs

Check against other drugs →

Cited in 5 documents

NeoHealth® ID 16131 · updated 5/14/2024